Memphasys secures exclusive $430K Thailand distribution deal for Felix sperm system
Memphasys (ASX:MEM) has signed a three-year Thailand distribution deal with IVF Envimed for its Felix sperm separation system. The exclusive contract guarantees A$430,500 over its three-year term, boosting the company’s South-East Asian revenue to A$1 million and driving total FY2...
Market Cap $238.4M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| BXN | Investor Update | 19/03/18 | ||
| BXN | Response to ASX Query Letter | PRICE SENSITIVE | 01/03/18 | |
| BXN | Appendix 4D and Interim Financial Report | PRICE SENSITIVE | 28/02/18 | |
| BXN | Unique NZ Colostrum Honey Dairy Product for China and S.E.A | PRICE SENSITIVE | 26/02/18 | |
| BXN | Additional New Products Launched for Direct Sales | PRICE SENSITIVE | 16/01/18 | |
| BXN Investor Update | |||
| 19/03/18 | |||
| BXN Response to ASX Query Letter | |||
| 01/03/18 | PRICE SENSITIVE | ||
| BXN Appendix 4D and Interim Financial Report | |||
| 28/02/18 | PRICE SENSITIVE | ||
| BXN Unique NZ Colostrum Honey Dairy Product for China and S.E.A | |||
| 26/02/18 | PRICE SENSITIVE | ||
| BXN Additional New Products Launched for Direct Sales | |||
| 16/01/18 | PRICE SENSITIVE | ||
